Foamix Pharmaceuticals Ltd. SEC Filings

Filed On	Filing
20 Mar 2020	EFFECT
19 Mar 2020	FORM 15-12B
18 Mar 2020	S-8 POS
18 Mar 2020	S-8 POS
18 Mar 2020	S-8 POS
18 Mar 2020	S-8 POS
18 Mar 2020	POS AM
18 Mar 2020	Form 4: Stern Stanley, Director Returned 42,359 shares to the issuer · Disposed of 86,228 Options (Disposition to Issuer)
12 Mar 2020	10-K
12 Mar 2020	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
11 Mar 2020	Form 4: Wiley Matthew T., Chief Commercial Officer Returned 114,074 shares to the issuer · Disposed of 196,365 Options (Disposition to Issuer)
11 Mar 2020	Form 4: Stuart Iain, Chief Scientific Officer Returned 103,636 shares to the issuer · Disposed of 255,362 Options (Disposition to Issuer)
11 Mar 2020	Form 4: Schwartz Aharon, Director Returned 112,200 shares to the issuer · Disposed of 157,886 Options (Disposition to Issuer)
11 Mar 2020	Form 4: Kazanchyan Anna, Director Returned 58,744 shares to the issuer · Disposed of 11,000 Options (Disposition to Issuer)
11 Mar 2020	Form 4: Hirsch Stanley, Director Returned 294,358 shares to the issuer · Disposed of 158,919 Options (Disposition to Issuer)
11 Mar 2020	Form 4: Harsch Mutya, CLO and General Counsel Returned 98,232 shares to the issuer · Disposed of 216,662 Options (Disposition to Issuer)
11 Mar 2020	Form 4: Hadar Ilan, CFO & Country Manager Returned 130,578 shares to the issuer · Disposed of 792,646 Options (Disposition to Issuer)
11 Mar 2020	Form 4: Domzalski David, Director Returned 324,028 shares to the issuer · Disposed of 1,196,741 Options (Disposition to Issuer)
11 Mar 2020	Form 4: Bruno Anthony D, Director Returned 75,007 shares to the issuer
11 Mar 2020	Form 4: Bright Rex, Director Disposed of 161,077 Options (Disposition to Issuer)

Comments